Skip to main content

Table 1 Comparison of the demographics and clinical characteristics between groups

From: Induction therapy with thymoglobulin or interleukin-2 receptor antagonist for Chinese recipients of living donor renal transplantation: a retrospective study

Variables

rATG (n = 41)

IL2-RA (n = 147)

P-value

Age, years

Receivers

31.0 ± 12.2

33.5 ± 8.3

0.110

Donors

47.1 ± 9.4

47.2 ± 10.8

0.976

Gender (m/f), n

26/15

123/24

0.005

Dialysis time, months

11.2 ± 8.3

12.2 ± 15.4

0.700

PRA score, %

30.0

4.9

< 0.001

Complete HLA mismatch, n (%)

13 (31.7)

1 (0.68)

< 0.001

Median follow-up time, weeks (range)

45 (17–96)

37 (17–73)

0.540

Renal transplantation history

2 (6.2)

1 (0.8)

0.106

  1. All values are mean ± standard deviation unless specified
  2. HLA = human leukocyte antigen; IL2-RA = IL-2 receptor antagonist; PRA = panel reactive antibody; rATG = rabbit antithymocyte globulin